PT Merck Tbk (IDX:MERK)

Indonesia · Delayed Price · Currency is IDR

4,130.00

+290.00 (7.55%)

Apr 28, 2026, 4:12 PM WIB

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biopharma	710.11B	722.56B	709.85B	734.25B	594.31B
Biopharma Growth	-1.72%	1.79%	-3.32%	23.55%	23.31%
Consumer Health	490.55B	314.19B	222.15B	291.03B	375.88B
Consumer Health Growth	56.14%	41.43%	-23.67%	-22.57%	290.36%
Others	-	-	29.43B	99.32B	94.20B
Others Growth	-	-	-70.37%	5.43%	21.43%
Total	1.20T	1.04T	961.43B	1.12T	1.06T
Total Growth	15.81%	7.83%	-14.51%	5.66%	62.29%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Indonesia	918.65B	826.48B	836.65B	934.25B	869.40B
Indonesia Growth	11.15%	-1.22%	-10.45%	7.46%	40.60%
Offshore Countries	282.02B	210.27B	124.78B	190.35B	194.99B
Offshore Countries Growth	34.12%	68.51%	-34.45%	-2.38%	420.10%
Total	1.20T	1.04T	961.43B	1.12T	1.06T
Total Growth	15.81%	7.83%	-14.51%	5.66%	62.29%

Source: S&P Global Market Intelligence.